2007
DOI: 10.1126/science.1150609
|View full text |Cite
|
Sign up to set email alerts
|

GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function

Abstract: The beta2-adrenergic receptor (beta2AR) is a well-studied prototype for heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) that respond to diffusible hormones and neurotransmitters. To overcome the structural flexibility of the beta2AR and to facilitate its crystallization, we engineered a beta2AR fusion protein in which T4 lysozyme (T4L) replaces most of the third intracellular loop of the GPCR ("beta2AR-T4L") and showed that this protein retains near-native pharmacologic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

31
1,279
2
14

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 1,289 publications
(1,338 citation statements)
references
References 46 publications
31
1,279
2
14
Order By: Relevance
“…Although high-throughput robotics now makes it possible to screen vast numbers of crystallization conditions, some proteins remain recalcitrant to crystallization. Many approaches have been developed to improve the success rate for crystallization, for example, systematically truncating the target protein, 1,2 methylating the lysine residues, 3,4 removing post-translational modifications, [5][6][7] screening homologues of the target protein for crystallization, 8,9 fusing the target protein to a carrier protein, [10][11][12][13] crystallizing racemic mixtures of the target protein, [14][15][16][17][18][19][20] and cocrystallizing the target protein with antibodies or other binding proteins. [21][22][23] A number of those methods have been reviewed.…”
Section: Introductionmentioning
confidence: 99%
“…Although high-throughput robotics now makes it possible to screen vast numbers of crystallization conditions, some proteins remain recalcitrant to crystallization. Many approaches have been developed to improve the success rate for crystallization, for example, systematically truncating the target protein, 1,2 methylating the lysine residues, 3,4 removing post-translational modifications, [5][6][7] screening homologues of the target protein for crystallization, 8,9 fusing the target protein to a carrier protein, [10][11][12][13] crystallizing racemic mixtures of the target protein, [14][15][16][17][18][19][20] and cocrystallizing the target protein with antibodies or other binding proteins. [21][22][23] A number of those methods have been reviewed.…”
Section: Introductionmentioning
confidence: 99%
“…In this context, experimentally validated GPCR homology models have proven to be valuable tools for lead identification, and the scientific literature flourished with successful rational drug design and virtual screening examples [7][8][9][10][11]. In 2007 Kobilka and coworkers unveiled the 3D crystal structure of the human β 2 -adrenergic receptor (β 2 -AR), finally providing the long awaited proof that the structure of GPCRs generally resembles that of rhodopsin [12][13][14][15]. Comparison between rhodopsin-based models of the β 2 -AR in complex with the inverse agonist carazolol and the corresponding crystal structure supports and encourages the applicability of GPCR homology modeling and molecular docking to computer-aided drug discovery, at least for qualitative purposes [16].…”
Section: Introductionmentioning
confidence: 99%
“…1 In membrane proteins, the presence of slow motion has been a hurdle for X-ray crystallography, as in the case of the 2 -adrenergic G-protein coupled receptor (GPCR). 2 Also for NMR spectroscopy, intermediate (ns-µs) motion tends to be an obstacle. In many amyloidogenic peptides and proteins, large parts of the primary sequence are often obscured and do not yield detectable resonances in solid-state NMR spectra, presumably due to dynamics.…”
mentioning
confidence: 99%